NAVB
Navidea Biopharmaceuticals Inc.
NAVB
NAVB
Delisted
NAVB was delisted on the 5th of October, 2023.
35 hedge funds and large institutions have $3.77M invested in Navidea Biopharmaceuticals Inc. in 2021 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 13 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Holders
35
Holding in Top 10
–
Calls
$369K
Puts
$390K
Top Buyers
| 1 | +$187K | |
| 2 | +$153K | |
| 3 | +$101K | |
| 4 |
Two Sigma Investments
New York
|
+$86.2K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$75.1K |
Top Sellers
| 1 | -$71K | |
| 2 | -$44K | |
| 3 | -$25K | |
| 4 |
Wolverine Trading
Chicago,
Illinois
|
-$8.1K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.17K |